Saroglitazar Improves Metabolic Profile, Hepatic Steatosis, Inflammation, and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review

被引:0
|
作者
Duseja, Ajay Kumar [1 ]
De, Arka [1 ]
Mehta, Manu [1 ]
Singh, Priya [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Chandigarh, India
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S1430
引用
收藏
页码:S1090 / S1090
页数:1
相关论文
共 50 条
  • [41] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Sachiko Hattori
    Kazuomi Nomoto
    Tomohiko Suzuki
    Seishu Hayashi
    Diabetology & Metabolic Syndrome, 13
  • [42] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Hattori, Sachiko
    Nomoto, Kazuomi
    Suzuki, Tomohiko
    Hayashi, Seishu
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [43] Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
    Jeong Woo Kim
    Young-Sun Lee
    Yang Shin Park
    Baek-Hui Kim
    Soo Yeon Lee
    Jong Eun Yeon
    Chang Hee Lee
    Scientific Reports, 10
  • [44] Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
    Kim, Jeong Woo
    Lee, Young-Sun
    Park, Yang Shin
    Kim, Baek-Hui
    Lee, Soo Yeon
    Yeon, Jong Eun
    Lee, Chang Hee
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [45] Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
    Katsarou, Angeliki
    Moustakas, Ioannis I.
    Pyrina, Iryna
    Lembessis, Panagiotis
    Koutsilieris, Michael
    Chatzigeorgiou, Antonios
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (17) : 1993 - 2011
  • [46] Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis
    Al Danaf, Layal
    Hussein Kamareddine, Mohammed
    Fayad, Emilie
    Hussain, Aniqa
    Farhat, Said
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (04) : 744 - U115
  • [47] Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis
    Layal Al Nadaf
    Mohammed Hussein Kamareddine
    Emilie Fayad
    Aniqa Hussain
    Said Farhat
    World Journal of Hepatology, 2022, (04) : 744 - 753
  • [48] Role of metabolic lipases and lipotoxicity in the development of non-alcoholic steatosis and non-alcoholic steatohepatitis
    Berlanga, Alba
    Guiu-Jurado, Esther
    Antonio Porras, Jose
    Aragones, Gemma
    Auguet, Teresa
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 (01): : 47 - 61
  • [49] Fatty Liver and Non-Alcoholic Steatohepatitis
    Saito, Takafumi
    Misawa, Keiko
    Kawata, Sumio
    INTERNAL MEDICINE, 2007, 46 (02) : 101 - 103
  • [50] STEATOSIS ASSESSMENT BY CAP™ IN PATIENTS WITH ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE
    Beaugrand, Michel
    Carmona, Damien
    Ziol, Marianne
    Perlemuter, Gabriel
    Naveau, Sylvie
    Prevot, Sophie
    Fournier, Celine
    Sandrin, Laurent
    Miette, Veronique
    Sasso, Magali
    HEPATOLOGY, 2011, 54 : 1147A - 1147A